Annual CFI
-$50.09 M
-$129.79 M-162.85%
December 31, 2023
Summary
- As of February 20, 2025, AVDL annual cash flow from investing activities is -$50.09 million, with the most recent change of -$129.79 million (-162.85%) on December 31, 2023.
- During the last 3 years, AVDL annual CFI has risen by +$19.63 million (+28.15%).
- AVDL annual CFI is now -162.85% below its all-time high of $79.70 million, reached on December 31, 2022.
Performance
AVDL Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$4.93 M
-$5.62 M-53.27%
September 30, 2024
Summary
- As of February 20, 2025, AVDL quarterly cash flow from investing activities is $4.93 million, with the most recent change of -$5.62 million (-53.27%) on September 30, 2024.
- Over the past year, AVDL quarterly CFI has dropped by -$23.00 million (-82.35%).
- AVDL quarterly CFI is now -90.35% below its all-time high of $51.11 million, reached on December 31, 2006.
Performance
AVDL Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$64.80 M
-$4.89 M-7.02%
September 30, 2024
Summary
- As of February 20, 2025, AVDL TTM cash flow from investing activities is $64.80 million, with the most recent change of -$4.89 million (-7.02%) on September 30, 2024.
- Over the past year, AVDL TTM CFI has increased by +$114.89 million (+229.35%).
- AVDL TTM CFI is now -26.36% below its all-time high of $87.99 million, reached on March 31, 2022.
Performance
AVDL TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
AVDL Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -162.8% | -82.3% | +229.3% |
| 3 y3 years | +28.1% | +105.3% | +203.8% |
| 5 y5 years | -35.5% | +105.3% | +203.8% |
AVDL Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -162.8% | at low | -88.3% | +105.3% | -26.4% | +203.8% |
| 5 y | 5-year | -162.8% | +28.1% | -88.3% | +105.3% | -26.4% | +190.3% |
| alltime | all time | -162.8% | +39.5% | -90.3% | +105.3% | -26.4% | +174.5% |
Avadel Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $4.93 M(-53.3%) | $64.80 M(-7.0%) |
| Jun 2024 | - | $10.55 M(-50.7%) | $69.69 M(-306.3%) |
| Mar 2024 | - | $21.39 M(-23.4%) | -$33.77 M(-32.6%) |
| Dec 2023 | -$50.09 M(-162.9%) | $27.93 M(+184.4%) | -$50.09 M(-9.2%) |
| Sep 2023 | - | $9.82 M(-110.6%) | -$55.15 M(-11.7%) |
| Jun 2023 | - | -$92.91 M(-1934.0%) | -$62.44 M(-246.9%) |
| Mar 2023 | - | $5.07 M(-77.9%) | $42.51 M(-46.7%) |
| Dec 2022 | $79.70 M(+40.0%) | $22.88 M(+806.3%) | $79.70 M(+10.5%) |
| Sep 2022 | - | $2.52 M(-79.1%) | $72.14 M(-11.9%) |
| Jun 2022 | - | $12.05 M(-71.5%) | $81.91 M(-6.9%) |
| Mar 2022 | - | $42.25 M(+175.8%) | $87.99 M(+54.6%) |
| Dec 2021 | $56.93 M(-181.7%) | $15.32 M(+24.6%) | $56.93 M(+16.5%) |
| Sep 2021 | - | $12.29 M(-32.2%) | $48.85 M(+79.2%) |
| Jun 2021 | - | $18.12 M(+62.0%) | $27.26 M(-138.0%) |
| Mar 2021 | - | $11.19 M(+54.6%) | -$71.76 M(+2.9%) |
| Dec 2020 | -$69.72 M(-280.1%) | $7.24 M(-177.9%) | -$69.72 M(-2.9%) |
| Sep 2020 | - | -$9.30 M(-88.5%) | -$71.79 M(+21.1%) |
| Jun 2020 | - | -$80.89 M(-711.6%) | -$59.27 M(-294.0%) |
| Mar 2020 | - | $13.23 M(+155.8%) | $30.56 M(-21.1%) |
| Dec 2019 | $38.72 M(-204.7%) | $5.17 M(+60.7%) | $38.72 M(-22.2%) |
| Sep 2019 | - | $3.22 M(-64.0%) | $49.76 M(-31.4%) |
| Jun 2019 | - | $8.95 M(-58.2%) | $72.57 M(+11.4%) |
| Mar 2019 | - | $21.39 M(+32.0%) | $65.15 M(-276.2%) |
| Dec 2018 | -$36.98 M(+135.6%) | $16.21 M(-37.7%) | -$36.98 M(-31.2%) |
| Sep 2018 | - | $26.02 M(+1604.3%) | -$53.72 M(-31.7%) |
| Jun 2018 | - | $1.53 M(-101.9%) | -$78.67 M(+22.1%) |
| Mar 2018 | - | -$80.74 M(>+9900.0%) | -$64.45 M(+310.5%) |
| Dec 2017 | -$15.70 M(-57.1%) | -$531.00 K(-149.3%) | -$15.70 M(+818.5%) |
| Sep 2017 | - | $1.08 M(-93.2%) | -$1.71 M(-38.1%) |
| Jun 2017 | - | $15.74 M(-149.2%) | -$2.76 M(-90.0%) |
| Mar 2017 | - | -$31.99 M(-337.7%) | -$27.63 M(-24.6%) |
| Dec 2016 | -$36.63 M(+15.4%) | $13.46 M(>+9900.0%) | -$36.63 M(-37.6%) |
| Sep 2016 | - | $26.00 K(-100.3%) | -$58.69 M(-17.7%) |
| Jun 2016 | - | -$9.13 M(-77.7%) | -$71.29 M(+44.6%) |
| Mar 2016 | - | -$40.99 M(+376.5%) | -$49.29 M(+55.3%) |
| Dec 2015 | -$31.73 M(-26.4%) | -$8.60 M(-31.6%) | -$31.73 M(+246.8%) |
| Sep 2015 | - | -$12.57 M(-197.7%) | -$9.15 M(-69.0%) |
| Jun 2015 | - | $12.87 M(-154.9%) | -$29.51 M(-23.8%) |
| Mar 2015 | - | -$23.43 M(-267.6%) | -$38.72 M(-10.1%) |
| Dec 2014 | -$43.08 M(-812.7%) | $13.98 M(-142.4%) | -$43.08 M(-22.0%) |
| Sep 2014 | - | -$32.93 M(-999.5%) | -$55.23 M(+144.5%) |
| Jun 2014 | - | $3.66 M(-113.2%) | -$22.59 M(-14.2%) |
| Mar 2014 | - | -$27.79 M(-1621.1%) | -$26.34 M(-535.8%) |
| Dec 2013 | $6.04 M(-60.9%) | $1.83 M(-725.7%) | $6.04 M(-40.6%) |
| Sep 2013 | - | -$292.00 K(+235.6%) | $10.18 M(-25.6%) |
| Jun 2013 | - | -$87.00 K(-101.9%) | $13.69 M(-11.1%) |
| Mar 2013 | - | $4.60 M(-22.9%) | $15.40 M(-0.3%) |
| Dec 2012 | $15.45 M | $5.96 M(+85.6%) | $15.45 M(+55.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2012 | - | $3.21 M(+97.3%) | $9.95 M(+164.7%) |
| Jun 2012 | - | $1.63 M(-64.9%) | $3.76 M(+325.0%) |
| Mar 2012 | - | $4.64 M(+904.5%) | $884.00 K(-351.9%) |
| Dec 2011 | -$351.00 K(-105.8%) | $462.00 K(-115.5%) | -$351.00 K(-110.2%) |
| Sep 2011 | - | -$2.98 M(+139.1%) | $3.45 M(-66.9%) |
| Jun 2011 | - | -$1.24 M(-136.5%) | $10.41 M(-9.3%) |
| Mar 2011 | - | $3.41 M(-20.0%) | $11.48 M(+90.5%) |
| Dec 2010 | $6.03 M(-124.8%) | $4.26 M(+6.8%) | $6.03 M(-38.1%) |
| Sep 2010 | - | $3.99 M(-2418.6%) | $9.73 M(+1729.9%) |
| Jun 2010 | - | -$172.00 K(-91.6%) | $532.00 K(-103.6%) |
| Mar 2010 | - | -$2.05 M(-125.7%) | -$14.59 M(-39.9%) |
| Dec 2009 | -$24.26 M(-2763.2%) | $7.97 M(-252.8%) | -$24.26 M(-37.3%) |
| Sep 2009 | - | -$5.21 M(-65.9%) | -$38.71 M(+35.6%) |
| Jun 2009 | - | -$15.29 M(+30.4%) | -$28.55 M(+63.7%) |
| Mar 2009 | - | -$11.72 M(+81.0%) | -$17.44 M(-2014.4%) |
| Dec 2008 | $911.00 K(-106.9%) | -$6.48 M(-231.2%) | $911.00 K(-80.1%) |
| Sep 2008 | - | $4.94 M(-218.2%) | $4.57 M(-178.9%) |
| Jun 2008 | - | -$4.18 M(-163.0%) | -$5.80 M(-6.9%) |
| Mar 2008 | - | $6.63 M(-335.4%) | -$6.23 M(-52.9%) |
| Dec 2007 | -$13.23 M(-118.2%) | -$2.82 M(-48.2%) | -$13.23 M(-132.5%) |
| Sep 2007 | - | -$5.43 M(+17.9%) | $40.70 M(-7.3%) |
| Jun 2007 | - | -$4.61 M(+1135.4%) | $43.92 M(-27.2%) |
| Mar 2007 | - | -$373.00 K(-100.7%) | $60.30 M(-17.0%) |
| Dec 2006 | $72.67 M(-1714.8%) | $51.11 M(-2408.7%) | $72.67 M(+232.8%) |
| Sep 2006 | - | -$2.21 M(-118.8%) | $21.83 M(-37.8%) |
| Jun 2006 | - | $11.77 M(-1.9%) | $35.08 M(+102.9%) |
| Mar 2006 | - | $11.99 M(+4183.9%) | $17.29 M(-484.2%) |
| Dec 2005 | -$4.50 M(-316.6%) | $280.00 K(-97.5%) | -$4.50 M(-12.3%) |
| Sep 2005 | - | $11.03 M(-283.3%) | -$5.13 M(-67.5%) |
| Jun 2005 | - | -$6.02 M(-38.6%) | -$15.81 M(+329.5%) |
| Mar 2005 | - | -$9.79 M(+2666.9%) | -$3.68 M(-277.1%) |
| Dec 2004 | $2.08 M(-102.5%) | -$354.00 K(-199.2%) | $2.08 M(-102.6%) |
| Sep 2004 | - | $357.00 K(-94.2%) | -$80.42 M(-0.4%) |
| Jun 2004 | - | $6.11 M(-251.4%) | -$80.78 M(-7.1%) |
| Mar 2004 | - | -$4.04 M(-95.1%) | -$86.93 M(+4.9%) |
| Dec 2003 | -$82.85 M(+5685.5%) | -$82.85 M(<-9900.0%) | -$82.85 M(<-9900.0%) |
| Sep 2003 | - | $0.00(-100.0%) | $4000.00(0.0%) |
| Jun 2003 | - | -$39.00 K(-190.7%) | $4000.00(-90.7%) |
| Mar 2003 | - | $43.00 K(-98.5%) | $43.00 K(-98.5%) |
| Dec 2002 | -$1.43 M(+21.9%) | - | - |
| Dec 2001 | -$1.18 M(+59.4%) | - | - |
| Dec 2000 | -$737.00 K(-121.7%) | - | - |
| Dec 1999 | $3.39 M(+140.2%) | - | - |
| Dec 1998 | $1.41 M(-188.3%) | - | - |
| Mar 1998 | - | $2.80 M(-1500.0%) | $2.80 M(-1500.0%) |
| Dec 1997 | -$1.60 M(-82.8%) | - | - |
| Dec 1996 | -$9.30 M | - | - |
| Mar 1996 | - | -$200.00 K | -$200.00 K |
FAQ
- What is Avadel Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals annual CFI year-on-year change?
- What is Avadel Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals quarterly CFI year-on-year change?
- What is Avadel Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals TTM CFI year-on-year change?
What is Avadel Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of AVDL is -$50.09 M
What is the all time high annual CFI for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high annual cash flow from investing activities is $79.70 M
What is Avadel Pharmaceuticals annual CFI year-on-year change?
Over the past year, AVDL annual cash flow from investing activities has changed by -$129.79 M (-162.85%)
What is Avadel Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of AVDL is $4.93 M
What is the all time high quarterly CFI for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high quarterly cash flow from investing activities is $51.11 M
What is Avadel Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, AVDL quarterly cash flow from investing activities has changed by -$23.00 M (-82.35%)
What is Avadel Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of AVDL is $64.80 M
What is the all time high TTM CFI for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high TTM cash flow from investing activities is $87.99 M
What is Avadel Pharmaceuticals TTM CFI year-on-year change?
Over the past year, AVDL TTM cash flow from investing activities has changed by +$114.89 M (+229.35%)